DNA Link Inc (127120) — Capital Reinvestment Ratio
Latest as of December 2023:
0.52x
DNA Link Inc (127120) has a Capital Reinvestment Ratio of 0.52x as of December 2023, meaning it reinvests 1% of its operating cash flow (₩1.51 Billion) in capital expenditures (₩786.91 Million). See how much free cash does DNA Link Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.52x
Capex / Operating Cash Flow
Operating Cash Flow
₩1.51 Billion
KRW
Capital Expenditures
₩786.91 Million
KRW
Data as of
Dec 2023
Most recent filing
DNA Link Inc Capital Reinvestment Ratio (2020–2022)
This chart tracks DNA Link Inc's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for DNA Link Inc (2020–2022)
Year-by-year Capital Reinvestment Ratio for DNA Link Inc from 2020 to 2022. For live market cap and broader valuation context, see market cap of DNA Link Inc.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 5.42x | ₩910.27 Million | ₩4.93 Billion | ▲ +319.1% |
| 2020 | 1.29x | ₩849.38 Million | ₩1.10 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow